Category Archives: Artificial Intelligence

Microsoft joins project on ethical Artificial Intelligence

Microsoft AI investmentMicrosoft announced it is joining the OpenAI ethical artificial intelligence project backed by Tesla‘s Elon Musk and Amazon, adding $1 billion to the project.

The partnership will be devoted to developing advanced AI models on Microsoft’s Azure cloud computing platform while adhering to “shared principles on ethics and trust,” the companies said in a joint release.

Microsoft
OpenAI’s main goal is to ensure artificial intelligence can be deployed safely and securely so its economic benefits are widely distributed. Microsoft will become the preferred partner for commercializing new “supercomputing” artificial intelligence technologies developed as part of the initiative.

“AI is one of the most transformative technologies of our time and has the potential to help solve many of our world’s most pressing challenges,” said Microsoft chief executive Satya Nadella.

Click here for more…

The future of Clinical Trials: how AI & Big Tech could help drug development

new drug process(CB Insights) – Testing new drugs is a slow, expensive, and manual process. Artificial intelligence has the potential to disrupt every stage of the clinical trials process — from matching eligible patients to studies to monitoring adherence and data collection.

    The process is inefficient for other stakeholders too: drug trials average nearly a decade, costing up to billions of dollars. Many trials fail due to enrollment issues. The $65B clinical trials market needs a makeover.

clinical trial phases

Artificial intelligence is touted as the magic bullet for everything, and the technology could have huge potential for streamlining the clunky clinical trial process, from IoT for remote monitoring, to machine learning for EHR processing, to AI-based cybersecurity for data protection.

Click here for more…

Enlitic closes funding to advance Artificial Intelligence solutions for radiologists

enlitic_logo

–(BUSINESS WIRE)– Enlitic, a privately-held company utilizing artificial intelligence to streamline medical imaging workflows for radiologists, announced the close of its $15M Series B financing round. The investment was led by Marubeni, with whom the company has been developing the Japanese market since 2017.

The round saw further investment from Capitol Health, who previously led the company’s Series A in 2016, as well as new participation from several top investors in Australia.

Kevin Lyman, CEO of Enlitic, commented:

“Radiologists have one of the hardest jobs in the world. They need to be able to identify thousands of different abnormalities in hundreds of different types of images. Even a single mistake can mean life or death, and yet they’re asked to read under tremendous time pressure in an environment full of distractions.”

Enlitic – deep learning medical imaging process
Enlitic - deep learning medical imaging process

Click here for more…